Caring Brands (CABR) FCF Margin (2024 - 2025)
Caring Brands (CABR) posted quarterly FCF Margin of 66858.95% for Q4 2025, down 831100.0% year-over-year from N/an in Q4 2024, and down 306.23% quarter-over-quarter from 16458.41% in Q1 2025.
Caring Brands (CABR) FCF Margin (2024 - 2025) Analysis & Trends
Caring Brands' FCF Margin history runs 2 years deep, the most recent figure standing at 66858.95% for Q4 2025.
- In Q4 2025, FCF Margin fell 831100.0% year-over-year to 66858.95%; the TTM figure through Dec 2025 stood at 36957.86% (changed N/A YoY), while the FY2025 annual figure was 40148.47%, changed N/A from the prior year.
- FCF Margin for Q4 2025 stood at 66858.95%, down from 16458.41% in the prior quarter.
- The five-year high for FCF Margin was 16458.41% in Q1 2025, with the low at 66858.95% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 7.41% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 21.80% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 14.87% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 26.25% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 8.76% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 13.41% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 17.84% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Caring Brands | 12.14 Mn | 10.32 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -66,858.95% |
| Mar 31, 2025 | -16,458.41% |
| Dec 31, 2024 | -58,547.96% |